Druck Icon

Eckert & Ziegler awards grants to young researchers in nuclear medicine

Berlin, October 15, 2008. This year's travel grants from Eckert & Ziegler Strahlen- und Medizintechnik AG (ISIN DE 0005659700) have been awarded to five nuclear medicine scientists from the USA, Japan, Sweden, Switzerland, and Austria. The prize-winners were selected by a jury from the European Association of Nuclear Medicine (EANM) from a total of 400 entries. Work in the fields of cancer and dementia diagnostics received recognition. The travel grants, which amount to 1,000 euros, were presented today on the occasion of the 10th anniversary of the Berlin-based company Eckert & Ziegler AG at the annual congress of the EANM in Munich to:

M. Samuraki, Ph.D., Toyama City Hospital, Japan: Prevalence of Reduced Glucose Metabolism or Gray-Matter Concentration in Healthy Apo E ? 4 Carriers: The Ishikawa Brain Imaging Study D. Putzer, Ph.D., Innsbruck Medical University, Austria: Correlation of 18F-FDG PET/CT and 68Ga-DOTA-TOC PET/CT with tissue markers of poor prognosis in neuroendocrine tumor disease A. Varrone, Ph.D., Karolinska Institutet, Sweden: Point Spread Function Reconstruction of High-Resolution Research Tomograph - HRRT - PET-Images Improves In Vivo Neuroreceptor Quantification C.B. Hruska, Ph.D., Mayo Clinic, USA: Concordance of Molecular Breast Imaging and Breast MRI findings: A retrospective review T. Cazaentre, Ph.D., Hôpitaux Universitaires de Genève, Switzerland: Predictive Factors for Response of Non Hodgkin Lymphomas (NHL) to Radioimmunotherapy (RIT) derived from FDG PET

"In presenting the 'EANM Eckert & Ziegler Abstract Award' we wish to encourage young researchers to present their ideas to a wider audience and to collaborate more in exchanging ideas with other researchers engaged in the field of nuclear medicine. We hope that this will help to ensure that the enormous progress which has been made in medical imaging can soon be transformed into more precise, faster or cheaper methods of diagnosis and therapy," explained Dr. Andreas Eckert, CEO of Eckert & Ziegler.

Eckert & Ziegler AG, which in 2008 will achieve sales of roughly 70 million euros with approx. 450 employees, is one of the world's largest providers of isotope component technology for radiation therapy and nuclear medicine. You can find further information about the Eckert & Ziegler travel grant at www.eanm.org.

The Board of Directors